Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
30 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2019-09-26 | 2019-10-10 | 94861 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Resolved | 2019-09-26 | 2019-10-10 | 94864 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2019-09-26 | 2020-01-17 | 94867 |
| PORTIA 21 | 0.03MG 0.15MG | TABLET | Resolved | 2019-09-26 | 2019-10-10 | 94870 |
| PORTIA 28 | 0.03MG 0.15MG | TABLET | Resolved | 2019-09-26 | 2019-10-10 | 94874 |
| TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2019-09-26 | 2020-03-10 | 94877 |
| TEVA-FAMOTIDINE | 40MG | TABLET | Resolved | 2019-09-26 | 2020-03-10 | 94880 |
| TEVA-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-09-26 | 2020-01-24 | 94896 |
| SEASONIQUE | 0.01MG 0.03MG 0.15MG | TABLET | Resolved | 2019-09-26 | 2021-03-25 | 94905 |
| SEASONALE | 0.03MG 0.15MG | TABLET | Resolved | 2019-09-27 | 2019-09-27 | 94940 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2019-10-03 | 2019-10-10 | 95370 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2019-10-03 | 2019-10-10 | 95373 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2019-10-03 | 2019-10-10 | 95378 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2019-10-03 | 2019-11-01 | 95381 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2019-10-03 | 2020-01-30 | 95384 |
| TEVA-LACOSAMIDE | 150MG | TABLET | Resolved | 2019-10-03 | 2019-10-10 | 95387 |
| TEVA-SIMVASTATIN | 80MG | TABLET | Resolved | 2019-10-03 | 2020-09-03 | 95390 |
| TEVA-QUININE | 300MG | CAPSULE | Resolved | 2019-10-03 | 2020-01-24 | 95393 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2019-10-03 | 2020-01-24 | 95396 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2019-10-03 | 2020-04-02 | 95408 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |